# Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer

> **NCT00938106** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 60 (estimated)

## Conditions studied

- Cervix Cancer

## Interventions

- **RADIATION:** optimised magnetic resonance image-guided intra-uterine brachytherapy

## Key facts

- **NCT ID:** NCT00938106
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938106, "Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00938106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*